? Project 2 The programmatic goals of this PSOC application are to understand how the physical characteristics of tumor cells within their 3D microenvironment impact the metabolic changes that are required to maintain their malignant state. Project 2 focuses on a key outcome of these metabolic changes, specifically, the generation of microvesicles (MVs), a class of extracellular shed vesicles that are shed from the plasma membranes of cancer cells. MVs are receiving increasing attention because of their roles in various aspects of cancer progression, including the induction of changes within the tumor microenvironment, the stimulation of tumor angiogenesis, and contributions to the metastatic process. However, although we understand some of the biochemical signals that trigger MV production, we know little about the physical determinants that drive their formation along cancer cell surfaces, nor about how the physical microenvironment influences their biogenesis, and ultimately their functions. We intend to probe these important issues in Project 2, through three lines of experimental inquiry. 1) Determine the physical relationships governing MV biogenesis and size distribution. We will examine the physical changes in membrane shape and protein-protein interactions that result in membrane curvature and the maturation of MVs. In particular, we will take advantage of our recent discovery that glycans (e.g. Mucin 1), which are highly expressed in cancer cells, have a key role in MV biogenesis. 2) Determine the reciprocal relationship between the physical properties of the extracellular matrix and MV formation. While the vast majority of studies on cancer cell metabolism have been performed in 2D cell culture settings, we will explore how the physical features of the 3D microenvironment influence the metabolic cues that drive MV biogenesis. 3) Establish physical read-outs such as vesicle size as indicators of MV function in tumor-stroma and reciprocal stroma-tumor vesicle transfer. We will implement the necessary engineering platforms to isolate MVs from other classes of vesicles in order to eliminate the ambiguity that often exists regarding studies using heterogeneous extracellular vesicle preparations and thereby define more precisely the functions of MVs. We will determine the effects of MVs on surrounding non-cancerous cells (adipose stromal cells and endothelial cells), and examine whether this leads to the production of new MVs (e.g. from adipose stromal cells) that might feed-back regulate the metabolism and invasiveness of tumor cells. These studies will take advantage of the two PSOC Cores, Tissue Microfabrication and Biophysics and Metabolic Imaging, and will complement and benefit from Projects 1 and 3. Collectively, they will shed new light on cancer cell metabolism and how it gives rise to MV biogenesis, with the expectation being that ultimately novel therapeutic strategies will emerge from these efforts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA210184-02
Application #
9339646
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2017-08-01
Budget End
2018-07-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Cornell University
Department
Type
DUNS #
872612445
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Goncalves, Marcus D; Hwang, Seo-Kyoung; Pauli, Chantal et al. (2018) Fenofibrate prevents skeletal muscle loss in mice with lung cancer. Proc Natl Acad Sci U S A 115:E743-E752
Iyengar, Neil M; Chen, I-Chun; Zhou, Xi K et al. (2018) Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian Women. Cancer Prev Res (Phila) 11:227-236
Zahid, H; Subbaramaiah, K; Iyengar, N M et al. (2018) Leptin regulation of the p53-HIF1?/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link. Int J Obes (Lond) 42:711-720
Hopkins, Benjamin D; Pauli, Chantal; Du, Xing et al. (2018) Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560:499-503
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Puca, Loredana; Bareja, Rohan; Prandi, Davide et al. (2018) Patient derived organoids to model rare prostate cancer phenotypes. Nat Commun 9:2404
van Helvert, Sjoerd; Storm, Cornelis; Friedl, Peter (2018) Mechanoreciprocity in cell migration. Nat Cell Biol 20:8-20
Beunk, Lianne; Brown, Kari; Nagtegaal, Iris et al. (2018) Cancer invasion into musculature: Mechanics, molecules and implications. Semin Cell Dev Biol :
Lourenço, Bianca N; Springer, Nora L; Ferreira, Daniel et al. (2018) CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling. Integr Biol (Camb) 10:145-158
Elacqua, Joshua J; McGregor, Alexandra L; Lammerding, Jan (2018) Automated analysis of cell migration and nuclear envelope rupture in confined environments. PLoS One 13:e0195664

Showing the most recent 10 out of 46 publications